Skip to main content

Month: April 2026

Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform

VANCOUVER, British Columbia, April 21, 2026 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces HealthTab™ has now screened more than 3,500 patients in community pharmacies across North East and North Central London. During an initial one-month pilot of HbA1c testing for diabetes screening, the Company completed 2,295 HbA1c tests across 57 locations, achieving a monthly per-location average 10 times higher than previously achieved in Canada. Expansion Roadmap The Company has published “The Path Forward,” a strategic update outlining the Company’s UK expansion strategy for its HealthTab point-of-care testing platform. The presentation is now available on the Company’s website at avricore.com/investor-kit. The update outlines Avricore’s progression from NHS-linked pilot programmes...

Continue reading

Sow Good Announces Transformative Acquisition of the Nachu Graphite Project, Positioning the Company as a Critical Minerals and Battery Anode Developer

IRVING, Texas, April 21, 2026 (GLOBE NEWSWIRE) — Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or the “Company”), announces a transformative acquisition that will position the Company as a critical minerals and battery anode developer supplying high-purity natural flake graphite to the global lithium-ion battery supply chain, while continuing to produce the freeze-dried treats for which it is known. The Company has entered into a definitive share purchase agreement (the “Share Purchase Agreement”) with Ryzon Materials Ltd (“Ryzon”) and the sellers named therein (the “Sellers”) to acquire 100% of the issued and outstanding shares (the “Transaction”) of wholly owned Tanzanian subsidiaries of Ryzon (the “Targets”). Following closing, the Company intends to focus on advancing the acquired project toward construction and production, with...

Continue reading

Asyad Group and Ligentia Join Forces to Accelerate Global Growth and Enhance Technology-Driven Supply Chain Solutions

Strategic acquisition expands Asyad’s global reach to over 70 locations worldwide, strengthens digital capabilities, and unlocks new opportunities for customers.Ligentia x Asyad GroupLigentia x Asyad GroupLigentia x Asyad GroupLigentia x Asyad GroupAbdulrahman Al Hatmi CEO Asyad GroupAbdulrahman Al Hatmi CEO Asyad GroupDan Gill Group CEO of LigentiaDan Gill Group CEO of LigentiaMUSCAT, Oman and LONDON, April 21, 2026 (GLOBE NEWSWIRE) — Asyad Group, a global integrated logistics provider, and Ligentia Group, a premier UK-based tech-enabled supply chain services provider, today announced a strategic transaction that will see Ligentia join Asyad Group. This landmark acquisition marks a significant milestone for both organizations, accelerating their global expansion and reinforcing their commitment...

Continue reading

Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion

WALNUT CREEK, Calif. and TOKYO, April 21, 2026 (GLOBE NEWSWIRE) — Dark Horse Consulting Group (“DHCG” or “the Group”) today announced the acquisition of CJ PARTNERS (“CJP”), a distinguished consulting and advisory firm specializing in bridging the gap between Western and Eastern therapeutic developers and stakeholders — including regulators (PMDA), investors, and commercial partners — to reduce entry risk, accelerate development programs, and maximize global development opportunities around the world. CJP, as a Dark Horse Consulting Group company, further expands DHCG’s Asian Pacific foothold. CJP specializes in cross-border strategy with a focus on Japan’s regenerative medicine ecosystem to enable global biotech and life science companies to enter, operate, and succeed in the Japanese market. CJP provides services across four pillars:...

Continue reading

Kering: Changes in the membership of the Board of Directors

 Kering – Press Release – Changes in the membership of the Board of Directors – 2026 04 21PRESS RELEASEApril 21, 2026CHANGES IN THE MEMBERSHIP OF THE BOARD OF DIRECTORS OF KERING The Board of Directors of Kering, on the recommendation of the Appointments and Governance Committee, will propose the appointment of two independent directors at the Annual General Meeting on May 28, 2026: Marie-Hélène Chenut and Laurent Kleitman.Marie-Hélène Chenut, a French national, held operational and strategic responsibilities at Chanel for over 35 years, with an international scope in marketing, business development, and talent development, before leading the Haute Couture division and the Haute Couture and Ready-to-Wear ateliers for nine years. Her industry expertise, understanding of business, operational and brand-related...

Continue reading

Neinor Homes announces an orderly leadership transition with the appointment of Jordi Argemí as CEO from 2027

Neinor Homes announces an orderly leadership transition with the appointment of Jordi Argemí as CEO from 2027Borja García-Egotxeaga will step down as CEO at the end of 2026 and will remain linked to the company as Senior Advisor following the transition period Jordi Argemí, current Deputy CEO and CFO, has been responsible for the company’s growth and success in recent years, ensuring full strategic continuity Additionally, it has been agreed to appoint Jordi Argemí as Co-CEO and will assume the role of CEO from 1 January 2027 Neinor has consolidated its position as Spain’s leading residential platform and enters this new phase from a position of strength to continue growing under its equity efficient strategyMadrid, 21 April 2026 – The Board of Directors of Neinor Homes (“Neinor”) has today approved an orderly succession plan under...

Continue reading

RAMSAY SANTE : Half-year Financial Report as at end of December 2025 disposal

   Paris, April 21, 2026        RAMSAY SANTE   Half-year Financial Report as at end of December 2025 disposal   This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay SantéRamsay Santé is the European leader in private hospitalisation and primary care. With 40,000 employees and 10,000 practitioners, the group welcomes 13 million patients each year in 492 facilities across five countries (France, Sweden, Norway, Denmark and Italy).As a mission-driven company, Ramsay Santé covers the entire care pathways in medicine, surgery, obstetrics, medical and rehabilitation care, mental health and primary care centres, with constant innovation to improves everyone’s health and ensures equitable access to secure and qualitative care. Facebook : https://www.facebook.com/RamsaySanteInstagram...

Continue reading

Q1 2026 trading statement

COMPANY ANNOUNCEMENT NO 18/2026 – April 21, 2026 EBIT up 25% in Q1 2026 driven by solid commercial performance and margin expansion Key Highlights Q1 2026Market share gains and solid commercial performance driven by our long‑term focus on selected growth categories Volume growth of 5.6% supported by the timing of Easter Net revenue growth of 3.3% with underlying growth of 6.8% adjusted for the exit from low-margin business Continued margin expansion and EBIT growth of 25% in the quarter Free cash flow improved by DKK 98m Full‑year 2026 outlook reiterated, despite increased macroeconomic and geopolitical uncertaintyLars Jensen, CEO of Royal Unibrew, comments: “Q1 2026 developed in line with our expectations, supported by the positive calendar effect from Easter and continued strong execution across markets. Growth in our...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS PLC – 20 04 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – [IDOX PLC – 20 04 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.